FHCLX Holdings — Select Health Care Portfolio
All 129 reported holdings of Select Health Care Portfolio (FHCLX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| ELI LILLY and CO | 8.03% | $464.10M |
| Danaher Corp. | 6.89% | $398.22M |
| JOHNSON and JOHNSON | 4.91% | $283.92M |
| Thermo Fisher Scientific, Inc. | 4.33% | $250.20M |
| Unitedhealth Group, Inc. | 3.49% | $201.56M |
| Alnylam Pharmaceuticals, Inc. | 2.40% | $138.91M |
| Gilead Sciences, Inc. | 2.21% | $127.71M |
| Boston Scientific Corp. | 2.17% | $125.61M |
| Ascendis Pharma A/s | 2.17% | $125.50M |
| Fidelity Revere Street Trust | 2.17% | $125.45M |
| Abbvie, Inc. | 2.03% | $117.57M |
| Ucb SA | 2.03% | $117.43M |
| Bio Techne Corp. | 1.70% | $98.19M |
| MERCK and CO INC | 1.60% | $92.60M |
| Argenx SE | 1.56% | $90.29M |
| Cvs Health Corp. | 1.29% | $74.60M |
| Nuvalent, Inc. | 1.28% | $73.96M |
| Natera, Inc. | 1.27% | $73.27M |
| Brightspring Health Services, Inc. | 1.23% | $70.93M |
| Viatris, Inc. | 1.20% | $69.59M |
| Moderna, Inc. | 1.18% | $68.43M |
| Cencora, Inc. | 1.14% | $65.99M |
| West Pharmaceutical Svcs, Inc. | 1.12% | $64.56M |
| Agilent Technologies, Inc. | 1.10% | $63.81M |
| Edwards Lifesciences Corp. | 1.09% | $62.95M |
| Xenon Pharmaceuticals, Inc. | 1.09% | $62.94M |
| Caris Life Sciences, Inc. | 1.08% | $62.70M |
| Royalty Pharma PLC | 1.08% | $62.45M |
| Cogent Biosciences, Inc. | 1.06% | $61.18M |
| Guardant Health, Inc. | 1.03% | $59.66M |
| Vaxcyte, Inc. | 1.03% | $59.62M |
| Veracyte, Inc. | 1.03% | $59.32M |
| Repligen Corp. | 0.99% | $57.02M |
| Spyre Therapeutics, Inc. | 0.97% | $55.86M |
| Jazz Pharmaceuticals PLC | 0.96% | $55.58M |
| Revolution Medicines, Inc. | 0.95% | $55.12M |
| Legend Biotech Corp. | 0.94% | $54.32M |
| Roche Holding AG | 0.93% | $54.00M |
| Privia Health Group, Inc. | 0.93% | $53.77M |
| Insmed, Inc. | 0.92% | $53.45M |
| Bruker Corp. | 0.87% | $50.06M |
| Oruka Therapeutics, Inc. | 0.84% | $48.76M |
| 10x Genomics, Inc. | 0.78% | $45.29M |
| Axsome Therapeutics, Inc. | 0.77% | $44.55M |
| Enliven Therapeutics, Inc. | 0.77% | $44.32M |
| Elevance Health, Inc. | 0.75% | $43.25M |
| Crinetics Pharmaceuticals, Inc. | 0.74% | $42.66M |
| Kiniksa Pharmaceuticals International PLC | 0.71% | $40.88M |
| Alignment Healthcare, Inc. | 0.69% | $39.83M |
| Lifestance Health Group, Inc. | 0.66% | $38.39M |
| Roivant Sciences Ltd. | 0.66% | $38.39M |
| Mineralys Therapeutics, Inc. | 0.64% | $37.17M |
| Kymera Therapeutics, Inc. | 0.63% | $36.64M |
| Medline, Inc. | 0.63% | $36.56M |
| Praxis Precision Medicines Inc. | 0.61% | $35.00M |
| Intuitive Surgical, Inc. | 0.55% | $31.85M |
| Disc Medicine, Inc. | 0.54% | $31.31M |
| Cg Oncology, Inc. | 0.54% | $31.14M |
| Heartflow, Inc. | 0.54% | $30.98M |
| Biogen, Inc. | 0.51% | $29.40M |
| Travere Therapeutics, Inc. | 0.47% | $26.89M |
| Sartorius Stedim Biotech | 0.46% | $26.59M |
| Viridian Therapeutics, Inc. | 0.46% | $26.43M |
| Beone Medicines Ltd. | 0.45% | $25.91M |
| Pharvaris Bv | 0.42% | $24.13M |
| Relay Therapeutics, Inc. | 0.41% | $23.60M |
| Newamsterdam Pharma Company NV | 0.40% | $23.24M |
| Mirum Pharmaceuticals, Inc. | 0.39% | $22.33M |
| Waystar Holding Corp. | 0.37% | $21.50M |
| Structure Therapeutics, Inc. | 0.37% | $21.24M |
| Scholar Rock Holding Corp. | 0.37% | $21.20M |
| Irhythm Technologies, Inc. | 0.35% | $20.50M |
| Amylyx Pharmaceuticals, Inc. | 0.35% | $20.38M |
| Zenas Biopharma, Inc. | 0.34% | $19.87M |
| Olema Pharmaceuticals, Inc. | 0.34% | $19.79M |
| Stoke Therapeutics, Inc. | 0.34% | $19.41M |
| Dianthus Therapeutics, Inc. | 0.33% | $19.29M |
| Kestra Medical Technologies, Inc. | 0.33% | $19.13M |
| Mbx Biosciences, Inc. | 0.33% | $18.88M |
| Veradermics, Inc. | 0.31% | $18.16M |
| Cytomx Therapeutics, Inc. | 0.31% | $18.00M |
| Viking Therapeutics, Inc. | 0.31% | $17.68M |
| Cleerly, Inc. | 0.27% | $15.49M |
| Kardium Inc/us | 0.26% | $14.83M |
| Insulet Corp. | 0.25% | $14.49M |
| Immunocore Holdings PLC | 0.25% | $14.45M |
| 10x Genomics, Inc. | 0.24% | $14.15M |
| Trevi Therapeutics, Inc. | 0.24% | $14.14M |
| Summit Therapeutics, Inc. | 0.24% | $14.03M |
| Jade Biosciences, Inc. | 0.23% | $13.47M |
| Damora Therapeutics, Inc. | 0.22% | $12.44M |
| Gmr Solutions, Inc. | 0.21% | $12.42M |
| Element Biosciences, Inc. | 0.21% | $12.41M |
| Candid Therapeutics | 0.20% | $11.73M |
| Fidelity Revere Street Trust | 0.19% | $10.76M |
| Edgewise Therapeutics, Inc. | 0.17% | $10.04M |
| Medical Microinstruments, Inc. | 0.17% | $9.87M |
| Tyra Biosciences, Inc. | 0.16% | $9.35M |
| Endeavor Biomedicines, Inc. | 0.15% | $8.91M |
| Aledade, Inc. | 0.14% | $8.27M |
| Insightec Ltd. | 0.14% | $8.18M |
| Galvanize Therapeutics | 0.14% | $8.06M |
| Shoulder Innovations, Inc. | 0.14% | $8.02M |
| Outset Medical, Inc. | 0.13% | $7.43M |
| Apogee Therapeutics, Inc. | 0.13% | $7.39M |
| Upstream Bio, Inc. | 0.12% | $6.69M |
| Alumis, Inc. | 0.11% | $6.51M |
| Annexon, Inc. | 0.11% | $6.50M |
| First Tracks Biotherapeutics, Inc. | 0.11% | $6.38M |
| Almar Biosciences, Inc. | 0.11% | $6.13M |
| Contineum Therapeutics, Inc. | 0.10% | $6.07M |
| Parabilis Medicines, Inc. | 0.10% | $5.98M |
| Cellcentric Ltd. | 0.10% | $5.80M |
| Tubulis Gmbh | 0.08% | $4.49M |
| Ocular Therapeutix, Inc. | 0.08% | $4.46M |
| Manus Bio, Inc. | 0.06% | $3.59M |
| Perceptive Capital Solutions Corp. | 0.06% | $3.21M |
| Wugen, Inc. | 0.05% | $3.10M |
| Zenas Biopharma, Inc. | 0.05% | $2.96M |
| Asimov, Inc. | 0.04% | $2.51M |
| Heal Thrive Holdings LLC | 0.04% | $2.32M |
| Dmed Biopharmaceutical Co. Ltd. | 0.04% | $2.29M |
| Hemab Therapeutics Holdings, Inc. | 0.03% | $1.85M |
| Immunome, Inc. | 0.02% | $1.41M |
| Saluda Medical, Inc. | 0.02% | $1.29M |
| Cyclerion Therapeutics, Inc. | 0.01% | $702.01K |
| Inmed Pharmaceuticals, Inc. | 0.01% | $476.09K |
| Elevatebio, LLC | 0.01% | $469.02K |
| Cyclerion Therapeutics, Inc. | 0.00% | $9.45K |
FHCLX overview: performance, fees, allocation and SEC filings